Brush-up Summaries

High throughput screening (HTS) relies on liquid handling devices, robotics, plate readers, and data processing software to automatically test a large number of biological, genetic, chemical, or pharmacological samples. 

Precision medicine helps clinicians tailor individual treatments, addressing genetic mutations, tumor microenvironment variations, and therapeutic resistance.

Researchers create and improve CRISPR-Cas mediated gene editing technologies based on prokaryotic CRISPR systems and eukaryotic DNA repair mechanisms.

The relationship between aging and cancer is complex, with several shared underlying mechanisms. 

Found circulating in peripheral blood, scientists use cell-free DNA (cfDNA) to assess genetic abnormalities, infections, cancer, transplant rejection, and cardiovascular disease.

Learn about quantitative PCR (qPCR), including its fundamentals, common applications, modes of detection, and key quantification methods.

As technologies advance, laboratory automation becomes reachable for researchers seeking high throughput approaches and reproducible results.

An essential staining technique with a long history, immunohistochemistry (IHC) is being upgraded for modern research and clinical applications.

As the closest reflection of biological phenotype, metabolomics provides critical information about human health and disease.

Allowing users to continually monitor biological signals over time, wearable biosensors pave the way toward personalized healthcare.

Proper ergonomics minimizes risk factors in the laboratory to optimize individuals’ performance and well-being.

From proteomics to pharmacokinetics, researchers turn to advances in liquid chromatography and mass spectrometry to identify and quantify components in different samples.

Making up the majority of all eukaryotic proteins, glycoproteins have a wide range of important physiological roles, from cell-cell signaling to disease pathogenesis. 

Small-scale successes in rare disease treatments prime large-scale industry innovations.

Learn about the tumor microenvironment (TME), a key influencer of cancer growth, spread, and treatment success.

New advancements in automation, AI, connectivity, sustainability, and more propel research forward.

By fusing antibody-producing cells with immortal myeloma cells, researchers produce reliable supplies of highly specific antibodies.

Scientists and clinicians increasingly use real world data (RWD) to make valuable discoveries that can be applied to the healthcare industry.

Scientists engineer therapeutic antibodies with improved stability and efficacy. 

By exploring the inner workings of individual cells, rather than averaging bulk populations, researchers identify rare and important cell subtypes.